Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 18Carcinoma, Renal Cell 8Neuroendocrine Tumors 6Tuberous Sclerosis 3Neoplasm Metastasis 3Kidney Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Seizures 2Neoplasms 2Gastro-enteropancreatic neuroendocrine tumor 2Carcinoma 2Carcinoid Tumor 2Astrocytoma 2von Hippel-Lindau Disease 1Unilateral Breast Neoplasms 1Tuberous Sclerosis Complex-associated Refractory Seizures 1Tuberous Sclerosis 2 1Thymus Neoplasms 1Stomach Diseases 1Skin Neoplasms 1Renal Cell Cancer Metastatic 1Recurrence 1Prostatic Neoplasms 1Primary Non-metastatic Breast Cancer 1Polycystic Kidney, Autosomal Dominant 1Malignant Carcinoid Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphoma 1

Interventions

vorolanib 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Renal Cell Cancer Metastatic × Everolimus × Clear all
NCT03095040 2021-02-08

CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

AnewPharma

Phase 3 Unknown
390 enrolled
Genitourinary

Renal Cell Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡